Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

Specimen Handling 60Magnetic Resonance Spectroscopy 41Carboplatin 32Gemcitabine 29Cyclophosphamide 29Cisplatin 25Biopsy 25Bevacizumab 24pembrolizumab 23Radiotherapy 22Paclitaxel 22Standard of Care 21Injections 21Drug Therapy 21Capecitabine 21fludarabine 20Oxaliplatin 20venetoclax 19Nivolumab 18toripalimab 17Interviews as Topic 17Dexamethasone 16Blood Specimen Collection 16tislelizumab 14Radiosurgery 14cemiplimab 13anlotinib 13Azacitidine 13Pemetrexed 12Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × CD3 Complex × 90 days × Clear all
NCT07408258 2026-06-04

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

OncoC4, Inc.

Phase 1 Not yet recruiting
20 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡